Literature DB >> 9125535

Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria.

J B De Souza1, K H Williamson, T Otani, J H Playfair.   

Abstract

This study was undertaken to explore early differences in cytokine production during nonlethal and lethal blood-stage murine malaria infections. Cytokine analysis of spleens during these infections showed that the principal difference between two nonlethal and two lethal Plasmodium species was the production of gamma interferon 24 h after infection with nonlethal parasites. In contrast, no increases in interleukin-4 production were observed in the first 24 h and tumor necrosis factor alpha levels increased equally in both nonlethal and lethal infections. During the later phase of infection with nonlethal parasites, both gamma interferon and interleukin-4 levels increased markedly a few days before parasite clearance. Early increases in gamma interferon production in nonlethal infections of Plasmodium yoelii and Plasmodium chabaudi were dose related and increased significantly with the size of the inoculum. Studies with the nonlethal P. yoelii suggest that the early gamma interferon response is mediated by T cells and natural killer cells, as it was reduced in athymic mice and in mice depleted of their natural killer cells by treatment with specific antiserum. Infecting mice with increasing numbers of lethal P. yoelii and Plasmodium berghei parasites did not increase the amount of gamma interferon, interleukin-4, and tumor necrosis factor alpha produced in a dose-dependent fashion. We conclude that one consequence of the early production of gamma interferon and tumor necrosis factor-alpha, particularly after nonlethal P. yoelii infection, may be to adjust the balance of T-helper cell subset activation, and probably that of other immune responses, so as to enhance the mechanisms that are essential for elimination of the parasites. This suggests that a successful vaccine should contain antigens capable of inducing such responses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125535      PMCID: PMC175180          DOI: 10.1128/iai.65.5.1593-1598.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Endogenous gamma interferon-independent host resistance against Listeria monocytogenes infection in CD4+ T cell- and asialo GM1+ cell-depleted mice.

Authors:  A Nakane; A Numata; Y Chen; T Minagawa
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

2.  Early gamma interferon production by natural killer cells is important in defense against murine listeriosis.

Authors:  P L Dunn; R J North
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

3.  IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism.

Authors:  S Mellouk; S J Green; C A Nacy; S L Hoffman
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

4.  Development of antimalaria immunity in mice lacking IFN-gamma receptor.

Authors:  M Tsuji; Y Miyahira; R S Nussenzweig; M Aguet; M Reichel; F Zavala
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

5.  Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor.

Authors:  J Taverne; N Sheikh; J B de Souza; J H Playfair; L Probert; G Kollias
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

6.  Protective immunity induced by B7/CD28-costimulated gamma delta T cells to the EL-4 lymphoma in allogenic athymic mice.

Authors:  Y Li; S A Newby; J V Johnston; K E Hellström; L Chen
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

7.  Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes.

Authors:  J P Kelly; G J Bancroft
Journal:  Eur J Immunol       Date:  1996-02       Impact factor: 5.532

8.  Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria.

Authors:  J M Vinetz; S Kumar; M F Good; B J Fowlkes; J A Berzofsky; L H Miller
Journal:  J Immunol       Date:  1990-02-01       Impact factor: 5.422

9.  Induction, specificity and elimination of asialo-GM1+ graft-versus-host effector cells of donor origin.

Authors:  T Ghayur; A Xenocostas; T A Seemayer; W S Lapp
Journal:  Scand J Immunol       Date:  1991-10       Impact factor: 3.487

10.  Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant.

Authors:  J B De Souza; I T Ling; S A Ogun; A A Holder; J H Playfair
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

View more
  71 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Gamma interferon production is critical for protective immunity to infection with blood-stage Plasmodium berghei XAT but neither NO production nor NK cell activation is critical.

Authors:  T Yoneto; T Yoshimoto; C R Wang; Y Takahama; M Tsuji; S Waki; H Nariuchi
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Macrophage migration inhibitory factor: a downregulator of early T cell-dependent IFN-gamma responses in Plasmodium chabaudi adami (556 KA)-infected mice.

Authors:  Diane Tshikudi Malu; Benoit Bélanger; François Desautels; Karine Kelendji; Esther Dalko; Jaime Sanchez-Dardon; Lin Leng; Richard Bucala; Abhay R Satoskar; Tatiana Scorza
Journal:  J Immunol       Date:  2011-04-25       Impact factor: 5.422

4.  Immune responses of NIH mice infected with avirulent and virulent strains of Plasmodium chabaudi adami single and mixed infections.

Authors:  M J Namazi; R S Phillips
Journal:  Korean J Parasitol       Date:  2010-03-18       Impact factor: 1.341

5.  Changes in the cytokine profile of lupus-prone mice (NZB/NZW)F1 induced by Plasmodium chabaudi and their implications in the reversal of clinical symptoms.

Authors:  M N Sato; P Minoprio; S Avrameas; T Ternynck
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

6.  Early cytokine production is associated with protection from murine cerebral malaria.

Authors:  Andrew J Mitchell; Anna M Hansen; Leia Hee; Helen J Ball; Sarah M Potter; John C Walker; Nicholas H Hunt
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

7.  Macrophages expressing heat-shock protein 65 play an essential role in protection of mice infected with Plasmodium yoelii.

Authors:  M Zhang; H Hisaeda; T Sakai; H Ishikawa; Y P Hao; Y Nakano; Y Ito; K Himeno
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

8.  Cytokine and antibody production during the course of resolution in Plasmodium yoelii 17XL-infected BALB/c mice treated with febrifugine and isofebrifugine mixture from leaves of Hydrangea macrophylla var. Otaksa.

Authors:  A Ishih; T Nagata; F Kobayashi; T Miyase; M Terada
Journal:  Parasitol Res       Date:  2004-08-26       Impact factor: 2.289

Review 9.  The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.

Authors:  K Artavanis-Tsakonas; J E Tongren; E M Riley
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

10.  Experimental malaria infection triggers early expansion of natural killer cells.

Authors:  Charles C Kim; Sunil Parikh; Joseph C Sun; Alissa Myrick; Lewis L Lanier; Philip J Rosenthal; Joseph L DeRisi
Journal:  Infect Immun       Date:  2008-09-29       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.